MHM Magazine

Treatment of major depressive disorder. S5 VOLOXIN 50 mg (extended release tablet). Reg. No.: 52/1.2/0952. Each extended release contains 50 mg desvenlafaxine succinate. S5 VOLOXIN 100 mg (extended release tablet). Reg. No.: 52/1.2/0953. Each extended release contains 100 mg desvenlafaxine succinate. For full prescribing information refer to the professional information approved by the medicines regulatory authority (05/2020).Trademarks are owned by or licensed to the Aspen Group of companies. © 2022 Aspen Group of companies or its licensor.All rights reserved. Pharmacare Limited. Co. Reg. No.: 1898/000252/06. Healthcare Park,Woodlands Drive,Woodmead, 2191. ZAR- DES-05-22-00001 06/2022 MEVOL2470 * These could be symptoms of major depressive disorder. Reference: 1. Stahl SM. Stahl’s Essential Psychopharmacology. Neuroscientific Basis and Practical Application. Cambridge Medicine 4th Ed. 2013;277-356